Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,411 | -35,573 | -35,821 | -35,778 | -21,475 |
| Depreciation Amortization | 2,126 | 2,255 | 2,952 | 1,942 | 1,428 |
| Accounts receivable | -26 | -188 | 1,034 | 490 | -1,286 |
| Accounts payable and accrued liabilities | -6 | -899 | -772 | -336 | 840 |
| Other Working Capital | -2,182 | 730 | -867 | -1,393 | 3,083 |
| Other Operating Activity | 11,489 | 3,938 | 3,862 | 1,084 | 2,568 |
| Operating Cash Flow | $-20,011 | $-29,737 | $-29,613 | $-33,990 | $-14,841 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 6,411 | -127 | -1,236 | -17,713 | -2,812 |
| Net Acquisitions | -7 | N/A | -2,010 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -2,700 | -77,498 | -72,800 |
| Sale Of Investment | N/A | N/A | 25,700 | 106,807 | 21,000 |
| Investing Cash Flow | $6,404 | $-127 | $19,754 | $11,596 | $-54,612 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 90,000 |
| Debt Repayment | -15 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 14,673 | 173 | 75 | 57,170 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -25,974 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -3,746 |
| Financing Cash Flow | $-15 | $14,673 | $173 | $75 | $117,450 |
| Exchange Rate Effect | -114 | -1 | -85 | -456 | 397 |
| Beginning Cash Position | 16,591 | 31,784 | 41,554 | 64,329 | 15,936 |
| End Cash Position | 2,854 | 16,591 | 31,784 | 41,554 | 64,329 |
| Net Cash Flow | $-13,736 | $-15,193 | $-9,771 | $-22,775 | $48,394 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,011 | -29,737 | -29,613 | -33,990 | -14,841 |
| Capital Expenditure | -33 | -185 | -1,243 | -17,713 | -2,812 |
| Free Cash Flow | -20,044 | -29,921 | -30,856 | -51,703 | -17,652 |